Summer School on Cardiovascular Prevention

A group of renowned specialists have developed an ambitious program starting on the pathogenesis of atherothrombosis, CV risk evaluation, including scores, biomarkers, imaging and genetics. Then, the focus will be on the different CV risk factors and their treatment, including pipeline therapies. Finally, the role of anti-inflammatory drugs and cardiac rehabilitation will be discussed.

Main topics addressed

• Pathogenesis of atherothrombosis                                                
• Stratification of cardiovascular risk: risk scores       
• Role of non-invasive imaging techniques in cardiovascular prevention
• Role of invasive imaging techniques in cardiovascular prevention
• Biomarkers: really useful in our daily practice?                         
• Hemostasis biomarkers  
• The role of genetics in CV prevention  
• The role of dyslipidemias in cardiovascular disease 
• Nutrition for cardiovascular prevention, lipoproteins and CV risk
• Present therapies for dyslipidemia. Mechanisms of action and evidence supporting their use
• The pipeline of therapies for dyslipidemia
• Antidiabetic therapy and cardiovascular risk reduction
• Management of smoking 
• Treating hypertension in 2022 
• Antithrombotic therapy in cardiovascular prevention 
• The role of cardiac rehabilitation
• Anti-inflammatory drugs: a new player in the field of CV prevention       

Learning outcomes

• Extensive knowledge on CV risk evaluation: scores, imaging, genetics, and biomarkers
• Current state-of-the-art on cardiovascular risk factors and their treatment, including pipeline therapies and the role of anti-inflammatory drugs
• The value of cardiac rehabilitation on cardiovascular prevention
• Gaps in evidence, in order to provide the students with a basis to initiate a research career